Virtu KCG Holdings’s Phio Pharmaceuticals PHIO Stock Holding History

Virtu KCG Holdings’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$45K	Hold	1	–	–	﹤0.01%	2615
2017 Q1	$47K	Buy	+1	New	+$43.2K	﹤0.01%	2854
2016 Q4	–	Hold	0	–	–	–	3231
2016 Q2	–	Hold	0	–	-$43K	–	3242
2016 Q1	–	Hold	0	–	–	–	2492
2015 Q4	–	Hold	0	–	–	–	3270
2015 Q3	–	Hold	0	–	–	–	3051
2015 Q2	–	Hold	0	–	–	–	3069
2015 Q1	–	Hold	0	–	–	–	2989
2014 Q4	–	Hold	0	–	–	–	3356
2014 Q3	–	Hold	0	–	-$167K	–	3942
2014 Q2	–	Hold	0	–	–	–	3138

Other funds holding PHIO

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu KCG Holdings's PHIO Position: Q2 2017 in Review

Virtu KCG Holdings held its Phio Pharmaceuticals (PHIO) position steady in Q2 2017 at 1 share worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Virtu KCG Holdings first reported a position in PHIO in Q1 2017 and has held it in 2 quarters since. The position peaked at $47K in Q1 2017. 5 funds tracked by Wall St. Rank hold PHIO as of Q2 2017.

Virtu KCG Holdings held 1 share of Phio Pharmaceuticals worth $45K as of Q2 2017.
Virtu KCG Holdings left its Phio Pharmaceuticals share count unchanged in Q2 2017.
Phio Pharmaceuticals made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2615 holding.
Virtu KCG Holdings first reported a position in Phio Pharmaceuticals in Q1 2017 and has held it in 2 quarters since.
Virtu KCG Holdings's Phio Pharmaceuticals position peaked at $47K in Q1 2017.
5 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.